LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
VIZZ sample distribution initiated nationwide to Eye Care Professionals Commercial product shipments to be initiated in October to consumers with...
Pharmaceutical
AssistRx Joins Second Annual Drug Channels Leadership Forum as Diamond Sponsor
Invite-only event will address today’s most pressing healthcare system challengesORLANDO, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- AssistRx, the advanced...
Medera Strengthens Leadership Team with Three Key Executive Appointments
Clinical operations, regulatory affairs, technical expertise, and corporate leadership additions support advancing gene therapy pipeline for cardiovascular diseasesBOSTON, Sept. 30,...
Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension
~ Topline results from the EXPLORE-OSA trial are anticipated in 1Q 2026 ~ RADNOR, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE)...
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
The combined company, Clywedog Therapeutics, will bring a portfolio that includes three differentiated, clinical stage product candidates which are being...
Reunion Neuroscience Announces First Patient Dosed in REKINDLE Phase 2 Clinical Trial of RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses
-- AjD Represents an Area of Significant Unmet Need; No U.S. Food and Drug Administration (FDA)-Approved Therapies Available -- --...
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
BEDFORD, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (Nasdaq: OCUL) (“Ocular”, the “Company”), an integrated biopharmaceutical company...
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular serious adverse events or dose-limiting...
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX:...
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025
Additional time enables LAVA Therapeutics to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics...
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
WAYNE, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
Long-Standing Partners in Science: Bioz and JULABO USA Drive Faster, Smarter Discovery
PALO ALTO, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Bioz, Inc., the pioneer in evidence-based product validation, is...
AUA Guidelines Recognize NGS in Recurrent UTI Care, Signaling Progress
NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid...
Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes
ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on...
PrimeRx Launches First-Ever Real-Time Marketplace Integration in the Dispensing Workflow
UNIONDALE, N.Y., Sept. 29, 2025 /PRNewswire/ -- PrimeRx announced the launch of its real-time pharmaceutical marketplace integration within PrimeRx Enterprise...
Crypto.com and Sharps Technology Partner to Strengthen Solana Ecosystem Growth Through Institutional Treasury Solutions
NEW YORK, Sept. 29, 2025/PRNewswire/ -- Crypto.com and Sharps Technology, Inc. (the "Company" or "STSS") (Nasdaq: "STSS" and "STSSW") today...
Teva’s Journey to 100% Renewable Electricity: Bold Targets, Bold Solutions
NORTHAMPTON, MA / ACCESS Newswire / September 29, 2025 / Reaching 100% renewable electricity in 10 years - that's a...
Fortified Health Security Acquires Latitude, Expands Cybersecurity Advisory Capabilities
BRENTWOOD, TN / ACCESS Newswire / September 29, 2025 / Fortified Health Security (Fortified), a Best in KLAS managed security...
Miracle CEO Defeats Cancer and Leads Medical AI Innovation at (OTC PINK:MDCE) Medical Care Technologies Inc.
MESA, AZ / ACCESS Newswire / September 29, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announces a new...
dHealth Intelligence Launches Revolutionary AI Agent That Transforms Personal Healthcare Management
ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2025 / Healthcare AI startup dHealth Intelligence just unveiled an AI agent...